Petition
“Allow NHS clinical trials for treatment-resistant depression using psilocybin”
Rejected
10 signatures
What the petition asks
Permit and fund NHS-led clinical trials using psilocybin for treatment-resistant depression. Create a clear, regulated pathway for research approval and delivery within NHS settings, ensuring strict clinical oversight, patient safety, and ethical governance.
Treatment-resistant depression affects thousands in the UK who do not respond to existing therapies, placing a major burden on individuals, families, and the NHS. Early clinical studies suggest psilocybin-assisted therapy may offer significant benefits when delivered in controlled settings. Current regulations limit research. Allowing NHS-led trials would provide robust UK evidence, improve understanding, and explore safe, effective alternatives for those with limited options.
Why it was rejected
There was already a petition about this issue. Duplicates are rejected so signatures collect in one place.
You may wish to sign the following petition, which calls for similar action:
Reschedule psilocybin from Schedule 1 to 2 to allow for use in medical research
Reschedule psilocybin from Schedule 1 to 2 to allow for use in medical research
Reschedule psilocybin from Schedule 1 to 2 to allow for use in medical research
Reschedule psilocybin from Schedule 1 to 2 to allow for use in medical research
Timeline
| 1 Apr 2026 | Petition opened for signatures |
| 21 Apr 2026 | Rejected by the Petitions Committee |
Key facts
Signatures
10
Status
Rejected
Rejected
21 Apr 2026
Follow this petition
Sign in to get an email when the government responds, a debate is scheduled or held, or the petition closes.
Source: the official petition page. Last checked 27 Aug 2026.